Sign Up to like & get
recommendations!
1
Published in 2022 at "Nucleic Acids Research"
DOI: 10.1093/nar/gkac641
Abstract: Abstract Current therapies for Duchenne muscular dystrophy (DMD) use phosphorodiamidate morpholino oligomers (PMO) to induce exon skipping in the dystrophin pre-mRNA, enabling the translation of a shortened but functional dystrophin protein. This strategy has been…
read more here.
Keywords:
mdx mice;
dystrophin restoration;
m23d;
force ... See more keywords